Epidemiological and clinical characteristics of COVID-19 mortality: a retrospective study
- PMID: 40130249
- PMCID: PMC11930819
- DOI: 10.3389/fmed.2025.1464274
Epidemiological and clinical characteristics of COVID-19 mortality: a retrospective study
Abstract
Background: The global impact of SARS-CoV-2 and its associated coronavirus disease (COVID-19) has necessitated urgent characterization of prognostic biomarkers. This study aimed to delineate the epidemiological and clinical predictors of mortality among hospitalized COVID-19 patients.
Methods: A retrospective cohort study was conducted on 123 patients with laboratory-confirmed COVID-19 admitted to Huoshenshan Hospital (Wuhan, China) from 1 February 2020 to 30 April 2020. Kaplan-Meier curve and multivariate Cox regression were used to assess the independent factors with survival time. Statistical significance was set at a p-value of <0.05.
Results: The cohort exhibited a mortality rate of 49.6% (61/123), with the critical clinical type (HR = 7.970, p = 0.009), leukocytosis (HR = 3.408, p = 0.006), and lymphopenia (HR = 0.817, p = 0.038) emerging as independent predictors of reduced survival. Critical-type patients demonstrated significantly elevated inflammatory markers (neutrophils: 10.41 ± 6.23 × 109/L; CRP: 104.47 ± 29.18 mg/L) and coagulopathy (D-dimer: 5.21 ± 2.34 μg/ml) compared to non-critical cases. Deceased patients exhibited pronounced metabolic derangements, including hyperglycemia (9.81 ± 2.07 mmol/L) and hepatic dysfunction (ALP: 174.03 ± 30.13 U/L).
Conclusion: We revealed the epidemiological and clinical features of different clinical types of SARS-CoV-2 as summarized in this paper. We found that critical type, leukocyte, and lymphocyte are risk factors that affect survival time, which could be an early and helpful marker to improve management of COVID-19 patients.
Keywords: COVID-19; SARS-CoV-2; d-dimer; epidemiology; leukocyte.
Copyright © 2025 Hu, Lu, Dong, Xia, Li, Wang, Rao, Wang and Tong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7. Respir Res. 2020. PMID: 32620118 Free PMC article.
-
Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.Front Immunol. 2021 Feb 16;12:581469. doi: 10.3389/fimmu.2021.581469. eCollection 2021. Front Immunol. 2021. PMID: 33664741 Free PMC article.
-
[Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):407-411. doi: 10.3760/cma.j.cn121430-20200302-00198. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32527342 Chinese.
-
The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115. doi: 10.1515/cclm-2020-0377. Clin Chem Lab Med. 2020. PMID: 32352397
-
Characterization of coagulopathy and outcomes in cancer patients with severe COVID -19 illness: Longitudinal changes in hospitalized cancer patients.Cancer Med. 2022 Oct;11(20):3771-3785. doi: 10.1002/cam4.4753. Epub 2022 Apr 26. Cancer Med. 2022. PMID: 35470980 Free PMC article. Review.
Cited by
-
Risk perception of severity or death from COVID-19: a systematic review of the factors associated.Front Public Health. 2025 May 26;13:1543629. doi: 10.3389/fpubh.2025.1543629. eCollection 2025. Front Public Health. 2025. PMID: 40491997 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous